ATC codes:
J01MA14
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis
ICD11 code:
ML32.00
INN
Moxifloxacin
Medicine type
Chemical agent
Antibiotic groups
List type
Core
(EML)
(EMLc)
(EMLc)
Additional notes
Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB contol.
Formulations
Oral > Solid > dispersible tablet:
100 mg
(EMLc)
Oral > Solid > tablet: 400 mg
Oral > Solid > tablet: 400 mg
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the transfer of listings for medicines for multi-drug resistant tuberculosis from the complementary to the core list of the EML and EMLc.